198 related articles for article (PubMed ID: 7911318)
41. Granulocyte-macrophage colony-stimulating factor accelerates hematopoietic recovery after autologous bone marrow or peripheral blood progenitor cell transplantation and high-dose chemotherapy for lymphoma.
Colombat P; Delain M; Desbois I; Domenech J; Binet C; Tabah I; Lamagnere JP; Linassier C
Bone Marrow Transplant; 1996 Aug; 18(2):293-9. PubMed ID: 8864437
[TBL] [Abstract][Full Text] [Related]
42. Hematologic recovery and survival of lymphoma patients after autologous stem-cell transplantation: comparison of bone marrow and peripheral blood progenitor cells.
Brice P; Marolleau JP; Pautier P; Makke J; Cazals D; Dombret H; D'Agay MF; Benbunan M; Gisselbrecht C
Leuk Lymphoma; 1996 Aug; 22(5-6):449-56. PubMed ID: 8882958
[TBL] [Abstract][Full Text] [Related]
43. High-dose therapy with autologous or allogeneic transplantation as salvage therapy for small cleaved cell lymphoma of follicular center cell origin.
Stein RS; Greer JP; Goodman S; Kallianpur A; Ahmed MS; Wolff SN
Bone Marrow Transplant; 1999 Feb; 23(3):227-33. PubMed ID: 10084253
[TBL] [Abstract][Full Text] [Related]
44. Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.
Navarro WH; Loberiza FR; Bajorunaite R; van Besien K; Vose JM; Lazarus HM; Rizzo JD
Biol Blood Marrow Transplant; 2006 May; 12(5):541-51. PubMed ID: 16635789
[TBL] [Abstract][Full Text] [Related]
45. Significance of molecular marker-positive cells after autologous peripheral-blood stem-cell transplantation for non-Hodgkin's lymphoma.
Hardingham JE; Kotasek D; Sage RE; Gooley LT; Mi JX; Dobrovic A; Norman JE; Bolton AE; Dale BM
J Clin Oncol; 1995 May; 13(5):1073-9. PubMed ID: 7738613
[TBL] [Abstract][Full Text] [Related]
46. Autologous bone marrow transplantation for acute myeloblastic leukemia in Europe: further evidence of the role of marrow purging by mafosfamide. European Co-operative Group for Bone Marrow Transplantation (EBMT).
Gorin NC; Labopin M; Meloni G; Korbling M; Carella A; Herve P; Burnett A; Rizzoli V; Alessandrino EP; Bjorkstrand B
Leukemia; 1991 Oct; 5(10):896-904. PubMed ID: 1835746
[TBL] [Abstract][Full Text] [Related]
47. Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.
Stahel RA; Jost LM; Cerny T; Pichert G; Honegger H; Tobler A; Jacky E; Fey M; Platzer E
J Clin Oncol; 1994 Sep; 12(9):1931-8. PubMed ID: 7521907
[TBL] [Abstract][Full Text] [Related]
48. High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO.
Avivi I; Arcaini L; Ferretti VV; Boumendil A; Finel H; Milone G; Zaja F; Liliana D; Musso M; Didier B; Bachy E; Wattad M; Nicolas-Virelizier E; Gramatzki M; Bourhis JH; Caillot D; Haenel A; Held G; Thieblemont C; Jindra P; Pohlreich D; Guilhot F; Kroschinsky F; Wahlin B; Scheid C; Ifrah N; Berthou C; Dreger P; Montoto S; Conconi A
Br J Haematol; 2018 Sep; 182(6):807-815. PubMed ID: 29984825
[TBL] [Abstract][Full Text] [Related]
49. Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia.
Demirer T; Petersen FB; Bensinger WI; Appelbaum FR; Fefer A; Rowley S; Sanders J; Chauncey T; Storb R; Lilleby K; Buckner CD
Bone Marrow Transplant; 1996 Jul; 18(1):29-34. PubMed ID: 8831992
[TBL] [Abstract][Full Text] [Related]
50. Faster engraftment but no reduction in infectious complications after peripheral blood stem cell transplantation compared to autologous bone marrow transplantation.
Larsson K; Björkstrand B; Ljungman P
Support Care Cancer; 1998 Jul; 6(4):378-83. PubMed ID: 9695206
[TBL] [Abstract][Full Text] [Related]
51. An economic evaluation of peripheral blood stem cell transplantation as an alternative to autologous bone marrow transplantation in multiple myeloma.
Duncan N; Hewetson M; Powles R; Raje N; Mehta J
Bone Marrow Transplant; 1996 Dec; 18(6):1175-8. PubMed ID: 8971391
[TBL] [Abstract][Full Text] [Related]
52. Peripheral blood stem cell (PBSC) mobilization and transplantation (PSCT) in patients with malignant lymphomas and solid tumors.
Richel DJ; Van der Wall E; Slaper J; Van der Schoot E; Rodenhuis S
Int J Artif Organs; 1993 Dec; 16 Suppl 5():71-5. PubMed ID: 7516919
[TBL] [Abstract][Full Text] [Related]
53. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
[TBL] [Abstract][Full Text] [Related]
54. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
[TBL] [Abstract][Full Text] [Related]
55. Factors that influence collection and engraftment of autologous peripheral-blood stem cells.
Bensinger W; Appelbaum F; Rowley S; Storb R; Sanders J; Lilleby K; Gooley T; Demirer T; Schiffman K; Weaver C
J Clin Oncol; 1995 Oct; 13(10):2547-55. PubMed ID: 7595706
[TBL] [Abstract][Full Text] [Related]
56. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
Martín A; Pérez-Simón JA; Caballero MD; López-Holgado N; Vázquez L; del Cañizo MC; San Miguel JF
Haematologica; 2005 Jan; 90(1):78-85. PubMed ID: 15642673
[TBL] [Abstract][Full Text] [Related]
57. Peripheral blood stem cell versus autologous bone marrow transplantation for Hodgkin's disease: equivalent survival outcome in a single-centre matched-pair analysis.
Perry AR; Peniket AJ; Watts MJ; Leverett D; Goldstone AH; Linch DC
Br J Haematol; 1999 Apr; 105(1):280-7. PubMed ID: 10233395
[TBL] [Abstract][Full Text] [Related]
58. Myelodysplasia and acute leukemia following high-dose chemotherapy and autologous bone marrow or peripheral blood stem cell transplantation.
Sobecks RM; Le Beau MM; Anastasi J; Williams SF
Bone Marrow Transplant; 1999 Jun; 23(11):1161-5. PubMed ID: 10382956
[TBL] [Abstract][Full Text] [Related]
59. CD34+-selected autologous peripheral blood stem cell transplantation (PBSCT) in patients with poor-risk hematological malignancies and solid tumors. A single-centre experience.
Nachbaur D; Fink FM; Nussbaumer W; Gächter A; Kropshofer G; Ludescher C; Niederwieser D
Bone Marrow Transplant; 1997 Nov; 20(10):827-34. PubMed ID: 9404922
[TBL] [Abstract][Full Text] [Related]
60. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry.
Williams CD; Harrison CN; Lister TA; Norton AJ; Blystad AK; Coiffier B; Taghipour G; Schmitz N; Goldstone AH;
J Clin Oncol; 2001 Feb; 19(3):727-35. PubMed ID: 11157024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]